Dr. Ashok Dattu Sastry, MD

Dr. Sastry practices at US Renal Care Sarasota Dialysis - HOPD in Sarasota, Florida.

Dr. Sastry's NPI, 1255372199, was assigned on June 10, 2006. Dr. Sastry graduated from Wayne State University School Of Medicine in 2001. Dr. Sastry holds Florida license ME95950.

Dr. Sastry's primary practice is US Renal Care Sarasota Dialysis - HOPD, at 1921 Waldemere St, Sarasota, FL 34239.

Dr. Sastry's primary practice is US Renal Care Sarasota Dialysis - HOPD in Sarasota, Florida. Dr. Sastry is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Florida Kidney Physicians. Dmand AI also links Dr. Sastry to 4 more hospitals, 3 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sastry practices, 11 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Sastry's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Sastry is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Sastry's licenses on file in 2 states: Florida and Texas.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia, kidney disease and parathyroid gland disorder among the conditions Dr. Sastry treats.

CMS data shows 3,875 Medicare services from Dr. Sastry across 15 procedure codes in 2024, for 834 Medicare patients. Medicare paid $325,203 for them.

CMS counts 834 Medicare patients who saw Dr. Sastry in 2024. The largest group is 75 to 84, with 360 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 3.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sastry's median patient age at 78, with 39% women.

In 2024, Dr. Sastry wrote 2,298 Medicare Part D claims for 351 patients. 78% of them were for generic drugs. CMS names the drug for 1,981 of them, across 48 drugs with 11 or more claims each, at $454,390 in total drug cost. In 2023, CMS named 1,641 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Sastry for performance year 2024, reported individually. Dr. Sastry accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Sastry, published from 2021 to 2022. The most frequent topics are Glomerulonephritis. Dr. Sastry's most frequent co-authors are Natalia Lattanzio, MD, Qassem Khaled Abdelal, MD and Talal Alkayali, MBBS.

CMS Open Payments shows 184 general payments to Dr. Sastry from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Travere Therapeutics, Inc. paid the most, $1,792.

Dmand AI lists 1 award for Dr. Sastry, most recently CMS Stage 1 EHR in 2013.

Dr. Sastry graduated from Wayne State University School Of Medicine in 2001. Dr. Sastry is a member of ACP, ASN and FMA.

Dr. Sastry is in network with 15 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.